undamentalytics Newsletter

Accendra Health vs Cosmos Health

Accendra Health is the larger business, with $2.76bn of revenue in fiscal 2025 against $65.3m for Cosmos Health (42.3 times as much). Cosmos Health grew faster (19.9% against 3.1%). Cosmos Health kept more of each dollar of sales as profit: a net margin of -29.3% against -39.8%.

Latest fiscal yearAccendra HealthACH, 2025Cosmos HealthCOSM, 2025
Revenue $2.76bn $65.3m
Revenue growth 3.1% 19.9%
Net income −$1.10bn −$19.1m
Operating margin 1.0% —
Net margin -39.8% -29.3%
Return on equity — -89.1%
Free cash flow −$293m −$8.5m
Cash $282m $715,674
Total debt $2.05bn $15.6m
Debt to equity — —
Dividend per share — —
Dividend yield — —
Share buybacks $10.2m —
Employees 6,500 163
Market value $20.2m $24.4m
Price vs our value range — —
Moat score 17 (Weak) 22 (Weak)
Insider trades, 12 months 0 buys, 0 sales 21 buys, 0 sales

Each figure is from the company's latest annual report and links to the page it comes from. Fiscal years can end on different dates. Market value and the value verdict use the delayed price shown on the stock pages. Not a recommendation.

Go deeper

Figures from each company's latest annual report filed with the SEC (10-K or 20-F), as reported, with the fiscal year shown. Not investment advice. How we read filings: methodology.